A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy
T-cell immunotherapies, such as CAR-T immunotherapy, are being developed against a wide variety of diseases. Here the authors report the feeder-free, scalable differentiation of human induced pluripotent cells (iPSCs) to T-cells with T-cell receptor dependent anti-tumour function in vitro and in viv...
Guardado en:
Autores principales: | Shoichi Iriguchi, Yutaka Yasui, Yohei Kawai, Suguru Arima, Mihoko Kunitomo, Takayuki Sato, Tatsuki Ueda, Atsutaka Minagawa, Yuta Mishima, Nariaki Yanagawa, Yuji Baba, Yasuyuki Miyake, Kazuhide Nakayama, Maiko Takiguchi, Tokuyuki Shinohara, Tetsuya Nakatsura, Masaki Yasukawa, Yoshiaki Kassai, Akira Hayashi, Shin Kaneko |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/12a17ede1fbe4df1bb06b871dd8b9d04 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Microhomology-assisted scarless genome editing in human iPSCs
por: Shin-Il Kim, et al.
Publicado: (2018) -
Dissecting transcriptomic signatures of neuronal differentiation and maturation using iPSCs
por: Emily E. Burke, et al.
Publicado: (2020) -
Efficient manipulation of gene dosage in human iPSCs using CRISPR/Cas9 nickases
por: Tao Ye, et al.
Publicado: (2021) -
Genetic aberrations in iPSCs are introduced by a transient G1/S cell cycle checkpoint deficiency
por: Ryoko Araki, et al.
Publicado: (2020) -
Modeling of lung phenotype of Hermansky–Pudlak syndrome type I using patient-specific iPSCs
por: Takahiro Suezawa, et al.
Publicado: (2021)